Opioid prescription and diabetes among Medicare beneficiaries
- PMID: 36610545
- PMCID: PMC9974602
- DOI: 10.1016/j.diabres.2023.110240
Opioid prescription and diabetes among Medicare beneficiaries
Abstract
Aims: To determine the prevalence of opioid prescriptions among U.S. Medicare beneficiaries by diabetes status, and predictors of opioid prescription among those with diabetes.
Methods: This retrospective study used claims data from the Centers for Medicare and Medicaid Services among beneficiaries age ≥ 65 years who were continuously enrolled in Part A, Part B, and Part D Medicare between 2017 and 2019 (N = 709,374). Logistic regression was used to determine the odds of opioid prescription among those with vs without diabetes; and, among those with diabetes, significant predictors of opioid prescription.
Results: Overall, the prevalence of any opioid prescription was 30.8 % among persons with diabetes and 24.2 % in those without diabetes (p < 0.001); chronic use was 8.0 % and 7.4 %, respectively (p < 0.001). Those with diabetes had a 45 % higher odds of having an opioid prescription compared to those without diabetes after adjusting for sociodemographic characteristics (OR = 1.45, 1.44-1.47). After adjustment for comorbidities/complications, the association reversed (OR = 0.83, 0.82-0.84). Persons with diabetes who had hypertension, obesity, CVD, neuropathy, amputation, liver disease, COPD, cancer, osteoporosis, depression, or alcohol/drug abuse had a 20 %-140 % higher odds of opioid prescription compared to those without these conditions.
Conclusions: Comorbidities and complications accounted for the higher odds of opioid prescriptions among those with diabetes.
Keywords: Comorbidities; Medicare; Opioids.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Krein SL, Heisler M, Piette JD, Makki F, Kerr EA. The effect of chronic pain on diabetes patients’ self-management. Diabetes Care. 2005;28(1):65–70. - PubMed
-
- Kirk JK, Hunter JC, Mihalko SL, Danhauer SC, Shumaker SA. Perspectives of pain in patients with type 2 diabetes. Expert review of endocrinology & metabolism. 2019;14(3):215–219. - PubMed
-
- Hassoon A, Bydon M, Kerezoudis P, Maloney PR, Rinaldo L, Yeh HC. Chronic low-back pain in adult with diabetes: NHANES 2009–2010. Journal of diabetes and its complications. 2017;31(1):38–42. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
